Oncology Drug Development in Practice 2021 (ODDP 2021) - Amsterdam (NL)

Kongressthemen
This program is of particular interest to drug development professionals in pharma and biotech companies. It is also relevant for (junior) physicians at academic or private clinical centers involved in the clinical development of new cancer therapies. They will benefit from participating in parts A and B combined or part B only, depending on their starting oncology knowledge.

Kongressorganizer (PCO)
Syneos Health, Aglaia Oncology Funds, Congress by design